Independent Director · Neumora Therapeutics, Inc. (NMRA)

Chair, Audit Committee

Matthew Fust director compensation at Neumora Therapeutics: $134K

Fiscal year 2025 director compensation for Matthew Fust at Neumora Therapeutics, Inc.. Every figure below is printed as the company filed it and cited to the filing it came from.

Director compensation as of the proxy filed April 17, 2026 (DEF 14A). Open the filing on EDGAR.

Free

Get Matthew Fust’s full pay file as a PDF — free

More than this page: up to 10 years of Matthew’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Also free: The Pay Desk, the weekly executive pay briefing.

Or track Matthew Fust and every company like it: Velarion Intel, free for 3 days, no card →

What they were paid

Neumora Therapeutics Director Compensation Table · all 3 fiscal years held
In US dollars, as Neumora Therapeutics reports it. Most recent year first. Totals are the company’s disclosed totals.
Fiscal yearCash feesStock awardsOption awardsOtherTotal
FY2025$90,625$0$43,632$0$134,257
FY2024$72,500$199,995$218,260—$490,755
FY2023$67,500—$375,969—$485,534

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Neumora Therapeutics, Inc. DEF 14A filed April 17, 2026, accession 0001193125-26-161489, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Neumora Therapeutics, Inc. filed document, accession 0001193125-26-161489. Every figure is read from that document and cited to the page and table it appears in. Filed April 17, 2026.

Get the Neumora Therapeutics Board Governance Report

$134,257 Matthew Fust, FY2025 total director compensation

$500

The free page is the headline figures. The board report is director pay, board composition and committee fees combined into the same kind of document.

Data as of April 17, 2026 · Source: Velarion Executive Compensation Database, deposited on Zenodo (doi:10.5281/zenodo.22283855).

How this board is paid

company policy · FY2025

Neumora Therapeutics pays directors a $45,000 cash retainer and $400,000 in equity.

Committees

FY2025 · as the proxy prints them

Audit (Chair) · Compensation

The rest of the Neumora Therapeutics board

FY2025 · as the company reported each
DirectorRoleFY2025 total
Alaa HalawaIndependent Director$106,132
David PiacquadIndependent Director$97,382
Kristina BurowIndependent Director$111,132
Maykin Ho, Ph.DIndependent Director$103,632
Paul L. BernsChair of the Board—

The full Neumora Therapeutics compensation record

free company brief

This page is one director within Neumora Therapeutics's record. The company brief lists every named executive and director, each linking to their own page.

Order NMRA

Add the email the receipt and the PDF go to, then press the report you want. Each button opens its own card payment on Stripe.

Receipt, invoice, and report delivery. Guest checkout, no account required, secure payment by Stripe.

Board Governance Report